“Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” USC Monthly Seminar Series Physical Sciences.

Slides:



Advertisements
Similar presentations
Inflammatory Bowel Disease: Overview
Advertisements

A Systems Approach to Personalized Medicine Talk and Discussion NASA Ames Mountain View, CA March 28, 2013 Dr. Larry Smarr Director, California Institute.
The Quantified Self: Personal Monitoring and the Control of Health Interview by Andre de Fusco Future in Review 2011 Laguna Beach, CA May 26, 2011 Dr.
Sequencing Genomics: The New Big Data Driver IntermezzoTalk SURFnet7, Part of GigaPort3 Utrecht, Netherlands December 7, 2011 Dr. Larry Smarr Director,
Reading Out the State of the Body and How it Changes Under Therapy Guest Lecture Pharmacy Informatics 2013 University of California San Diego June 7, 2013.
Calit2-Living in the Future " Keynote Sharecase 2006 University of California, San Diego March 29, 2006 Dr. Larry Smarr Director, California Institute.
Bringing Mexico Into the Global LambdaGrid Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E. Gruber.
Large Memory High Performance Computing Enables Comparison Across Human Gut Microbiome of Patients with Autoimmune Diseases and Healthy Subjects XSEDE.
Deep Self - Quantifying the State of Your Body Invited Talk NextMed / MMVR20 San Diego February 21, 2013 Dr. Larry Smarr Director, California Institute.
Cyberinfrastructure for Advanced Marine Microbial Ecology Research and Analysis (CAMERA) Invited Talk CONNECT Board Meeting La Jolla, CA April 26, 2006.
Science is Not Enough: The Need for Planetary Design of Geopolitics Invited Talk-Panel on Planetary Data, Planetary Governance DESIGNING GEOPOLITICS An.
Quantifying and Visualizing the State of Your Body Remote Talk To: TopCoder Innovation Summit, Orlando Fl From: October 2, 2012 Dr. Larry Smarr.
Exploring Our Inner Universe Using Supercomputers and Gene Sequencers Physics Department Colloquium UC San Diego October 24, 2013 Dr. Larry Smarr Director,
An MRI Showed My Sigmoid Colon Wall Was Thickened and Inflamed.
Discussion Janssen La Jolla Research and Development La Jolla, CA
“Integrating Healthcare Informatics, Imaging, and Systems Biology-A Personal Example” Plenary Lecture 2nd IEEE Conference on Healthcare Informatics, Imaging,
Leveraging Biomedical Big Data: Quantified Self & Beyond Invited Talk FutureMed Singularity University NASA Ames Campus February 5, 2013 Dr. Larry Smarr.
Personal Data Tracking and the Digital Transformation of Healthcare Invited Talk University of Illinois Silicon Valley Round Table Palo Alto, CA December.
Personal Genetics A Self-Discovery Platform. © 23andMe, Inc.2 Personal Genetics--Why Now? People want to know Information is empowering Genetics research.
“Building US/Mexico Collaborations Using Optical Networks” Opening Workshop Welcome Big Data Big Network 2 Calit2’s Qualcomm Institute February 10, 2014.
“Using Data Analytics to Discover the 100 Trillion Bacteria Living Within Each of Us” Invited Talk New Applications of Computer Analysis to Biomedical.
“Finding the Patterns in the Big Data From Human Microbiome Ecology” Invited Talk Exponential Medicine November 10, 2014 Dr. Larry Smarr Director, California.
The NIH Human Microbiome Project
“Personalized Medicine, Colorectal Cancer and Gut Bacteria”
Dalia Munoz.  Its an inflammatory bowel disease (IBD) that causes a long- lasting inflammation in your digestive tract.
Crohn’s disease - A Review of Symptoms and Treatment
Building a Community Cyberinfrastructure to Support Marine Microbial Ecology Metagenomics Center for Earth Observations and Applications Advisory Committee.
“The Quantified Self Movement: The Technologies That Are Revolutionizing Health and Fitness” Panel Discussion MIT Enterprise Forum San Diego UC San Diego.
Commercializing Space: From the Moon to Mars Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E.
“Inflammation, Gut Microbiome, Bacteriophages, and the Initiation of Colorectal Cancer” Seminar Lecture City of Hope Pasadena, CA October 20, 2014 Dr.
My N=1 Experience Pioneer Session: "N=1: Pioneers of Self-Tracking“ Panel at the Genomes, Environment, and Traits Conference Harvard Medical School Cambridge,
“Mapping the Human Gut Microbiome in Health and Disease Using Sequencing, Supercomputing, and Data Analysis” Invited Talk Delivered by Mehrdad Yazdani,
“Measuring the Human Brain-Gut Microbiome-Immune System Dynamics: a Big Data Challenge” Plenary Talk 45 th Annual Meeting of the Behavior Genetics Association.
“The Digital Transformation of Healthcare”
Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics.
“Using Data Analytics to Discover the 100 Trillion Bacteria Living Within Each of Us” Invited Talk Ayasdi Menlo Park, CA December 5, 2014 Dr. Larry Smarr.
“Toward Novel Human Microbiome Surveillance Diagnostics to Support Public Health” Invited Talk Institute for Public Health University of California San.
“Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” IBD Conference Speaker Series.
“Quantified Self- On Being a Personal Genomic Observatory” Keynote in the “Humans as Genomic Observatories” Meeting Session in the Genomics Standards Consortium.
“The Human Microbiome and the Revolution in Digital Health” The Florida Institute for Human and Machine Cognition Pensacola Evening Lecture Series Pensacola,
“Using Supercomputing & Advanced Analytic Software to Discover Radical Changes in the Human Microbiome in Health and Disease” Invited Remote Presentation.
“Creating a High Performance Cyberinfrastructure to Support Analysis of Illumina Metagenomic Data” DNA Day Department of Computer Science and Engineering.
Developing a North American Global LambdaGrid Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E.
“Comparative Human Microbiome Analysis” Remote Video Talk to CICESE Big Data, Big Network Workshop Ensenada, Mexico October 10, 2013 Dr. Larry Smarr Director,
“Individual, Consumer-Driven Care of the Future -- Taking Wellness One Step Further” Closing Keynote Address The World Congress 2 nd Annual Leadership.
713 Lecture 15 Host metagenomics. Progression of techniques Culture based –Use phenotypes and genotypes to ID Non-culture based, focused on 16S rDNA –Clone.
Innovative Research Alliances Invited Talk IUCRP Fellows Seminar UCSD La Jolla, CA July 10, 2006 Dr. Larry Smarr Director, California Institute for Telecommunications.
“Inspired by Carl: Exploring the Microbial Dynamics Within” Invited Talk Looking in the Right Direction: Carl Woese and the New Biology University of Illinois,
“Living in a Microbial World” Global Health Program Council on Foreign Relations New York, NY April 10, 2014 Dr. Larry Smarr Director, California Institute.
“Frontiers of Self-Tracking” Plenary Talk Quantified Self Conference 2012 Stanford University September 15, 2012 Dr. Larry Smarr Director, California Institute.
“Deciphering the Dynamic Coupling of the Human Immune System and the Gut Microbiome” Overview Data-Enabled Life Sciences Research (DELSA) DELSA Workshop.
“Observing the Dynamics of the Human Immune System Coupled to the Microbiome in Health and Disease” CASIS Workshop on Biomedical Research Aboard the ISS.
“Quantifying Your Superorganism Body Using Big Data Supercomputing” ACM International Workshop on Big Data in Life Sciences BigLS 2014 Newport Beach, CA.
“Assay Lab Within Your Body: Biometrics and Biomes” Invited Lecture TSensors Summit La Jolla, CA November 12, 2014 Dr. Larry Smarr Director, California.
“Quantifying the Time Progression of the Interaction of the Human Immune System with the Gut Microbiome” Research Council Presentation UC San Diego Health.
“CAMERA Goes Live!" Presentation with Craig Venter National Press Club Washington, DC March 13, 2007 Dr. Larry Smarr Director, California Institute for.
Joe Pekny, Professor Chemical Engineering Director, e-Enterprise Center Discovery Park Marietta Harrison, Professor Medicinal Chemistry & Molecular Pharmacology.
“The UCSD Big Data Freeway System” Invited Short Talk Workshop on “Enriching Human Life and Society” UC San Diego February 6, 2014 Dr. Larry Smarr Director,
Lecture Science & Entertainment Exchange National Academy of Sciences Los Angeles June 13, 2013 Dr. Larry Smarr Director, California Institute for Telecommunications.
“Using Genetic Sequencing to Unravel the Dynamics of Your Superorganism Body” Weekly Bioinformatics Seminar Series UC San Diego La Jolla, CA October 17,
“Adding Consumer-Generated and Microbiome Data to the Electronic Medical Record” Using Big Data to Advance Healthcare Panel National Health Policy Conference.
“Genomics: The CAMERA Project" Invited Talk 5 th Annual ON*VECTOR International Photonics Workshop UCSD February 28, 2006 Dr. Larry Smarr Director,
1 Modelling and Simulation EMBL – Beyond Molecular Biology Physics Computational Biology Chemistry Medicine.
“OptIPuter: From the End User Lab to Global Digital Assets" Panel UC Research Cyberinfrastructure Meeting October 10, 2005 Dr. Larry Smarr.
Page  2 Accutane, a medication used to treat acne, has recently been linked to dangerous health conditions such as inflammatory bowel disease (IBD).
“ Building an Information Infrastructure to Support Microbial Metagenomic Sciences " Presentation to the NBCR Research Advisory Committee UCSD La Jolla,
“Connecting Body Time Series to Macro Body Changes”
“Linking Phenotype Changes to Internal/External Longitudinal Time Series in a Single Human” Invited Presentation at EMBC ‘16 38th International Conference.
“Machine Learning in Healthcare Diagnostics”
Volume 16, Issue 3, Pages (September 2014)
Presentation transcript:

“Tracking Immune Biomarkers and the Human Gut Microbiome: Inflammation, Crohn's Disease, and Colon Cancer” USC Monthly Seminar Series Physical Sciences in Oncology Center Los Angeles, CA May 17, 2013 Dr. Larry Smarr Director, California Institute for Telecommunications and Information Technology Harry E. Gruber Professor, Dept. of Computer Science and Engineering Jacobs School of Engineering, UCSD http://lsmarr.calit2.net

Abstract Colon Cancer is the most common cancer among Inflammatory Bowel Disease (IBD) patients and IBD is one of the three leading high-risk factors for Colon Cancer. In 2012 it was found, by using genetic sequencing of the gut microbiome, that Fusobacteria sequences were enriched in colorectal carcinomas (CRC). To explore this possible link between inflammation, gut microbes, and colon cancer I have turned my own body into a "genomic observatory." I have been tracking over 100 blood/stool biomarkers in my own body every few months for the last five years, with a focus on immune variables. Using key biomarkers and imaging technologies I diagnosed myself as having late-onset Crohn's Disease, one of the two forms of IBD. Besides obtaining one million SNPs of my human genome, I have collaborated with the J. Craig Venter Institute to metagenomically sequence my gut microbiome at three different times during a period of high inflammation. My microbiome was compared with 50 other subjects, sequenced by the NIH Human Microbiome Project--35 healthy and the remainer with IBD. I discovered that at the height of my inflammation (CRP~30), I had 8% relative abundance of Fusobacteria, 40x healthy subjects. Following antibiotic/corticosteroid therapy the Fusobacteria were reduced 90-fold. The next step is to move to high-throughput integrated personal "omics" to refine the host-microbiome dynamics. With these new tools of computationally-intensive omics, there is a hope that we will gain new insights into the pathogenisis of CRC.

Visualizing Time Series of 150 LS Blood and Stool Variables, Each Over 5-10 Years Calit2 64 megapixel VROOM

Episodic Peaks in Inflammation Followed by Spontaneous Drops Only One of My Blood Measurements Was Far Out of Range--Indicating Chronic Inflammation 27x Upper Limit Episodic Peaks in Inflammation Followed by Spontaneous Drops Antibiotics Antibiotics Normal Range<1 mg/L Normal Complex Reactive Protein (CRP) is a Blood Biomarker for Detecting Presence of Inflammation

Lactoferrin is an Antibacteria Glycoprotein Shed from WBC Neutrophils Into Stool Sample 124x Healthy Upper Limit Typical Lactoferrin Value for Active IBD Normal Range <7.3 µg/mL Antibiotics Antibiotics Lactoferrin Sequesters Iron

Colonoscopy Images Show Inflamed Pseudopolyps in 6 inches of Sigmoid Colon May 2011 Dec 2010

I Obtained the MRI Slices From UCSD Medical Services Confirming the IBD (Crohn’s) Hypothesis: Finding the “Smoking Gun” with MRI Imaging Liver I Obtained the MRI Slices From UCSD Medical Services and Converted to Interactive 3D Working With Calit2 Staff & DeskVOX Software Transverse Colon Small Intestine Descending Colon Sigmoid Colon Threading Iliac Arteries Major Kink Diseased Sigmoid Colon MRI Jan 2012 Cross Section

affects the thickness of the intestinal wall. MRE Reveals Inflammation in 6 Inches of Sigmoid Colon Thickness 15cm – 5x Normal Thickness “Long segment wall thickening in the proximal and mid portions of the sigmoid colon, extending over a segment of approximately 16 cm, with suggestion of intramural sinus tracts. Edema in the sigmoid mesentery and engorgement of the regional vasa recta.” – MRI report DeskVOX 3D Image Crohn's disease affects the thickness of the intestinal wall. Having Crohn's disease that affects your colon increases your risk of colon cancer. Clinical MRI Slice Program

An MRI Shows Sigmoid Colon Wall Thickened Indicating Probable Diagnosis of Crohn’s Disease

Why Did I Have an Autoimmune Disease like IBD? Despite decades of research, the etiology of Crohn's disease remains unknown. Its pathogenesis may involve a complex interplay between host genetics, immune dysfunction, and microbial or environmental factors. --The Role of Microbes in Crohn's Disease So I Set Out to Quantify All Three! Paul B. Eckburg & David A. Relman Clin Infect Dis. 44:256-262 (2007) 

Now Comparing 163 Known IBD SNPs with 23andme SNP Chip I Wondered if Crohn’s is an Autoimmune Disease, Did I Have a Personal Genomic Polymorphism? From www.23andme.com Polymorphism in Interleukin-23 Receptor Gene — 80% Higher Risk of Pro-inflammatory Immune Response ATG16L1 IRGM NOD2 SNPs Associated with CD Now Comparing 163 Known IBD SNPs with 23andme SNP Chip

Fine Time Resolution Sampling Reveals Distinct Dynamics of Innate and Adaptive Immune System Normal Normal

Four Immune Biomarkers Over Time Compared with Four Signs/Symptoms Here Immune biomarkers are normalized 0 to 1, with 1 being the highest value in five years Source: Photo of Calit2 64-megapixel VROOM

To Map My Gut Microbes, I Sent a Stool Sample to the Venter Institute for Metagenomic Sequencing Funding Provided by UCSD School of Health Sciences Shipped Stool Sample December 28, 2011 I Received a Disk Drive April 3, 2012 With 35 GB FASTQ Files Weizhong Li, UCSD NGS Pipeline: 230M Reads Only 0.2% Human Required 1/2 cpu-yr Per Person Analyzed!  Gel Image of Extract from Smarr Sample-Next is Library Construction Manny Torralba, Project Lead - Human Genomic Medicine J Craig Venter Institute January 25, 2012

CAMERA and NIH Funded Weizhong Li Group’s Metagenomic Computational NextGen Sequencing Pipeline Reads QC Raw reads HQ reads: Bowtie/BWA against Human genome and mRNAs Filter human Filtered reads Filter duplicate CD-HIT-Dup For single or PE reads Unique reads FR-HIT against Non-redundant microbial genomes Cluster-based Denoising Read recruitment Filter errors Taxonomy binning Further filtered reads Velvet, SOAPdenovo, Abyss ------- K-mer setting FRV Assemble Visualization Contigs Mapping BWA Bowtie ORF-finder Megagene Contigs with Abundance ORFs Pfam Tigrfam COG KOG PRK KEGG eggNOG tRNA-scan rRNA - HMM Cd-hit at 95% Hmmer RPS-blast blast Non redundant ORFs tRNAs rRNAs Cd-hit at 60% Core ORF clusters Cd-hit at 30% 1e-6 Function Pathway Annotation Protein families PI: (Weizhong Li, UCSD): NIH R01HG005978 (2010-2013, $1.1M)

Additional Phenotypes Added from NIH HMP For Comparative Analysis Download Raw Reads ~100M Per Person 5 Ileal Crohn’s, 3 Points in Time 6 Ulcerative Colitis, 1 Point in Time 35 “Healthy” Individuals 1 Point in Time

~4500 Reference Genomes with Strains and Viruses We Computationally Align 230M Illumina Short Reads With a Reference Genome Set & Then Visually Analyze ~4500 Reference Genomes with Strains and Viruses

From Taxonomy to Function: Analysis of LS Clusters of Orthologous Groups (COGs) Analysis: Weizhong Li & Sitao Wu, UCSD

Gut Microbiome Metagenomic Analysis: From Short Reads to Taxonomic and Gene Diversity Analyzed Healthy and IBD Patients: LS, 13 Crohn's Disease & 11 Ulcerative Colitis Patients, + 150 HMP Healthy Subjects Gordon Compute Time ~1/2 CPU-Year Per Sample > 200,000 CPU-Hours so far Gordon RAM Required 64GB RAM for Most Steps 192GB RAM for Assembly Gordon Disk Required 8TB for All Subjects Input, Intermediate and Final Results Venter Sequencing of LS Gut Microbiome: 230 M Reads 101 Bases Per Read 23 Billion DNA Bases Enabled by a Grant of Time on Gordon from SDSC Director Mike Norman

Microbial Ecology Diagnostics Phyla Gut Microbial Abundance Without Viruses: LS, Crohn’s, UC, and Healthy Subjects Source: Weizhong Li, UCSD; Calit2 FuturePatient Expedition LS Crohn’s Ulcerative Colitis Healthy Toward Noninvasive Microbial Ecology Diagnostics

Microbiome “Dysbiosis” We Find Major Shifts in Microbial Ecology Between Healthy and Two Forms of IBD Microbiome “Dysbiosis” or “Mass Extinction”? On the IBD Spectrum Explosion of Proteobacteria Collapse of Bacteroidetes

Almost All Abundant Species (≥1%) in Healthy Subjects Are Severely Depleted in Larry’s Gut Microbiome

Top 20 Most Abundant Microbial Species In LS vs Top 20 Most Abundant Microbial Species In LS vs. Average Healthy Subject 152x Number Above LS Blue Bar is Multiple of LS Abundance Compared to Average Healthy Abundance Per Species 765x 148x 849x 483x 220x 201x 169x 522x Source: Sequencing JCVI; Analysis Weizhong Li, UCSD LS December 28, 2011 Stool Sample

Major Changes in LS Microbiome Before and After 1 Month Antibiotic & 2 Month Prednisone Therapy Reduced 45x Reduced 90x Therapy Greatly Reduced Two Phyla, But Massive Reduction in Bacteroidetes And Large % Proteobacteria Remain Small Changes With No Therapy How Does One Get Back to a “Healthy” Gut Microbiome?

Gamma- proteobacteria LS Time Series Gut Microbiome Classes vs. Healthy, Crohn’s, Ulcerative Colitis Class Gamma- proteobacteria

Does Intestinal Inflammation Select for Pathogenic Strains That Can Induce Further Damage? AIEC LF82 “Adherent-invasive E. coli (AIEC) are isolated more commonly from the intestinal mucosa of individuals with Crohn’s disease than from healthy controls.” “Thus, the mechanisms leading to dysbiosis might also select for intestinal colonization with more harmful members of the Enterobacteriaceae* —such as AIEC— thereby exacerbating inflammation and interfering with its resolution.” E. coli/Shigella Phylogenetic Tree Miquel, et al. PLOS ONE, v. 5, p. 1-16 (2010) Sebastian E. Winter , et al., EMBO reports VOL 14, p. 319-327 (2013) *Family Containing E. coli

Greatly Reduced by Therapy Larry Relative Abundance S A B1 LF82 AIEC LF82 Cluster Greatly Reduced by Therapy LS001 LS002 LS003 Larry Relative Abundance E. Coli/Shigella Strains At Three Times Our E. coli/Shigella Phylogenetic Tree Constructed From 122 Genomes (2012) =3X 2011 Strains

Our New 2013 Reference Genome Set contains 761 Ecoli strains =6x our 2012 Set D A B1 B2 E S Colored nodes are the 38 strains in the 2011 PNAS paper

Sebastian E. Winter, Christopher A. Lopez & Andreas J. Bäumler, Inflammation Enables Anaerobic Respiration Which Leads to Phylum-Level Shifts in the Gut Microbiome Sebastian E. Winter, Christopher A. Lopez & Andreas J. Bäumler, EMBO reports VOL 14, p. 319-327 (2013)

Sebastian E. Winter, Christopher A. Lopez & Andreas J. Bäumler, Horizontal Gene Transfer Provides Pathogenic Strains Additional Fitness Factors Leading to Growth Advantage Sebastian E. Winter, Christopher A. Lopez & Andreas J. Bäumler, EMBO reports VOL 14, p. 319-327 (2013) Image from Zhang S., et al. Infect Immun 71: 1–12 (2003)

IBD is one of the three leading high-risk factors for Colon Cancer Does the Gut Microbiome Intermediate Between Inflammation & the Development of Colorectal Cancer? Colon Cancer is the most common cancer among Inflammatory Bowel Disease (IBD) patients IBD is one of the three leading high-risk factors for Colon Cancer The root cause of CRC is unclear, but inflammation is a well-recognized risk factor (Wu et al. 2009; McLean et al. 2011)

Fusobacteria Are Found To Be More Abundant In Colonrectal Carcinoma (CRC) Tissue et al. et al.

LS Time Series Gut Microbiome Classes vs LS Time Series Gut Microbiome Classes vs. Healthy, Crohn’s, Ulcerative Colitis Class Fusobacteria

Distribution of Relative Species Abundance Across the Fusobacteria Phyla in LS001

Class Fusobacteria Is Enriched in Human Colon Cancer Tumors “…the relative abundance of Fusobacterium was highly enriched in the population of tumor versus normal samples…” Kostic, A. D., et al. “Genomic analysis identifies association of Fusobacterium with colorectal carcinoma”, v. 22: 292–298 (2012)

Could the Presence of Fusobacterium Nucleatum Be an Early Indicator of a Transition to CRC? Fusobacterium nucleatum Relative Abundance Across LS, Healthy, UC, and CD LS Crohn’s

Does Fusobacterium Have a Causal Role in the Development of Human Colorectal Cancer? “Therefore, our findings of a tumoral enrichment of Fusobacterium spp. in colorectal carcinoma suggest the possibility that these organisms may contribute to tumorigenesis, perhaps in a limited subset of patients, most conceivably by an inflammatory mediated mechanism.” “Our results do not prove a causal relationship between Fusobacterium and colorectal cancer; the establishment or repudiation of such a relationship will require further studies of colorectal cancer in both human subjects and animal models of the disease.” Kostic, A. D., et al. “Genomic analysis identifies association of Fusobacterium with colorectal carcinoma”, v. 22: 292–298 (2012)

The Bacterial Driver-Passenger Model for Colorectal Cancer Initiation Is Fusobacterium nucleatum a “Driver” or a “Passenger” “Early detection of Colorectal Cancer (CRC) is one of the greatest challenges in the battle against this disease & the establishment of a CRC-associated microbiome risk profile could aid in the early identification of individuals who are at high risk and require strict surveillance.” Tjalsma, et al. Nature Reviews Microbiology v. 10, 575-582 (2012)

Integrative Personal Omics Profiling Using 100x My Quantifying Biomarkers Cell 148, 1293–1307, March 16, 2012 Michael Snyder, Chair of Genomics Stanford Univ. Genome 140x Coverage Blood Tests 20 Times in 14 Months tracked nearly 20,000 distinct transcripts coding for 12,000 genes measured the relative levels of more than 6,000 proteins and 1,000 metabolites in Snyder's blood

Proposed UCSD/JCVI Integrated Omics Pipeline Source: Nuno Bandiera, UCSD

UCSD Center for Computational Mass Spectrometry Becoming Global MS Repository ProteoSAFe: Compute-intensive discovery MS at the click of a button MassIVE: repository and identification platform for all MS data in the world Source: Nuno Bandeira, Vineet Bafna, Pavel Pevzner, Ingolf Krueger, UCSD proteomics.ucsd.edu

Phil Papadopoulos, SDSC, Calit2, PI A “Big Data Freeway System” Connecting Users to Remote Campus Clusters & Scientific Instruments Phil Papadopoulos, SDSC, Calit2, PI